Compare Aurobindo Pharma with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA DIVIS LABORATORIES AUROBINDO PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 10.9 37.9 28.7% View Chart
P/BV x 1.4 10.5 13.8% View Chart
Dividend Yield % 0.7 0.5 136.0%  

Financials

 AUROBINDO PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
DIVIS LABORATORIES
Mar-21
AUROBINDO PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0233,913 26.1%   
Low Rs3331,824 18.3%   
Sales per share (Unadj.) Rs422.8262.5 161.1%  
Earnings per share (Unadj.) Rs92.074.7 123.0%  
Cash flow per share (Unadj.) Rs110.084.4 130.4%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Avg Dividend yield %0.60.7 84.6%  
Book value per share (Unadj.) Rs374.3350.1 106.9%  
Shares outstanding (eoy) m585.94265.47 220.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.610.9 14.7%   
Avg P/E ratio x7.438.4 19.2%  
P/CF ratio (eoy) x6.234.0 18.1%  
Price / Book Value ratio x1.88.2 22.1%  
Dividend payout %4.326.8 16.3%   
Avg Mkt Cap Rs m397,398761,517 52.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35,3508,258 428.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m247,74669,694 355.5%  
Other income Rs m3,809627 607.7%   
Total revenues Rs m251,55570,321 357.7%   
Gross profit Rs m81,48028,611 284.8%  
Depreciation Rs m10,5542,556 412.9%   
Interest Rs m74521 3,547.1%   
Profit before tax Rs m73,99026,660 277.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,0986,818 294.8%   
Profit after tax Rs m53,89219,843 271.6%  
Gross profit margin %32.941.1 80.1%  
Effective tax rate %27.225.6 106.2%   
Net profit margin %21.828.5 76.4%  
BALANCE SHEET DATA
Current assets Rs m198,23567,906 291.9%   
Current liabilities Rs m106,65217,284 617.1%   
Net working cap to sales %37.072.6 50.9%  
Current ratio x1.93.9 47.3%  
Inventory Days Days1910 201.5%  
Debtors Days Days52878 5.9%  
Net fixed assets Rs m135,77845,963 295.4%   
Share capital Rs m586531 110.4%   
"Free" reserves Rs m218,71392,415 236.7%   
Net worth Rs m219,29992,946 235.9%   
Long term debt Rs m1,6840-   
Total assets Rs m334,013113,869 293.3%  
Interest coverage x100.31,270.5 7.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 121.2%   
Return on assets %16.417.4 93.8%  
Return on equity %24.621.3 115.1%  
Return on capital %33.828.7 117.8%  
Exports to sales %53.80-   
Imports to sales %16.418.8 87.0%   
Exports (fob) Rs m133,248NA-   
Imports (cif) Rs m40,61513,127 309.4%   
Fx inflow Rs m133,24858,877 226.3%   
Fx outflow Rs m44,94613,341 336.9%   
Net fx Rs m88,30245,536 193.9%   
CASH FLOW
From Operations Rs m33,28919,469 171.0%  
From Investments Rs m5,987751 796.9%  
From Financial Activity Rs m-13,648-349 3,911.8%  
Net Cashflow Rs m25,83119,872 130.0%  

Share Holding

Indian Promoters % 48.8 51.9 93.9%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.3 36.8 104.2%  
FIIs % 20.8 18.5 112.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 48.1 100.2%  
Shareholders   338,639 309,397 109.5%  
Pledged promoter(s) holding % 14.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


May 24, 2022 03:31 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - AVON ORGANIC COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS